Discover Products, Get Discovered.
Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Since 2020, DOB Equity has backed 6 African startups across 10 disclosed funding rounds totaling $21.9M, most heavily in Kenya and Health Tech.
DOB Equity is a Dutch family-backed impact investment firm founded in 1997. It operates as an evergreen fund, providing patient capital to innovative, scalable companies in East Africa that contribute to a more social, sustainable, and resilient society while delivering long-term profitability. The firm maintains offices in the Netherlands and Kenya. DOB Equity invests primarily in early-stage ventures, including seed and venture rounds, with a focus on Kenya. Its investments span health tech, fintech, and edtech sectors, supporting companies such as Ilara Health, Zuri Health, Kwara, and Zydii. Between December 2020 and February 2024, it participated in six funding rounds totaling $14.6 million. The firm collaborates with co-investors like Launch Africa Ventures and Globivest, and works closely with entrepreneurs on governance, risk mitigation, and impact aligned with the United Nations Sustainable Development Goals.
Data updated · Jul 29, 2026
Sign in to see all 6 portfolio products
Free account — full portfolios, timelines, and the weekly funding digest
Sign in to see all 10 rounds
Free account — full portfolios, timelines, and the weekly funding digest
DOB Equity has backed 6 African startups across 10 disclosed funding rounds tracked on Liners, totaling $21.9M since 2020.
Mostly Seed: 6 of its 10 tracked rounds are at that stage, followed by Venture (Round not Specified) (2).
Its tracked rounds lean toward Health Tech (5), Agri Tech (2), Fintech (2), and 1 more sector.
DOB Equity most often shares rounds with Mercy Corps Ventures (2 shared deals), Impacc (2 shared deals), Globivest (2 shared deals).
DOB Equity has backed Ilara Health, Zuri Health, Kwara, and Zydii in Kenya. These investments total $14.6 million across six rounds from December 2020 to February 2024.